| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 23.20M | 10.29M | 8.51M | 71.39M |
| Gross Profit | -1.57M | 21.28M | 8.52M | 6.36M | 70.70M |
| EBITDA | 116.82M | 20.06M | 4.67M | -2.71M | 67.02M |
| Net Income | 115.08M | 18.04M | 4.34M | -3.48M | 67.02M |
Balance Sheet | |||||
| Total Assets | 409.63M | 282.86M | 237.24M | 232.57M | 149.22M |
| Cash, Cash Equivalents and Short-Term Investments | 3.08M | 1.09M | 14.75M | 34.51M | 2.16M |
| Total Debt | 29.58M | 31.75M | 316.09K | 496.75K | 0.00 |
| Total Liabilities | 30.72M | 32.86M | 1.29M | 1.50M | 172.71K |
| Stockholders Equity | 378.91M | 250.00M | 235.95M | 231.08M | 149.05M |
Cash Flow | |||||
| Free Cash Flow | 8.19M | 7.24M | 3.61M | 637.70K | 627.69K |
| Operating Cash Flow | 8.19M | 7.24M | 3.61M | 637.70K | 627.69K |
| Investing Cash Flow | -17.29M | -47.86M | -21.02M | -45.61M | -23.57M |
| Financing Cash Flow | 11.15M | 26.97M | -2.23M | 77.68M | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | C$395.21M | 4.33 | 20.24% | 1.43% | -73.34% | 40.59% | |
71 Outperform | C$213.77M | 4.54 | 26.60% | ― | 550.81% | ― | |
70 Outperform | C$17.01M | 2.03 | 49.20% | 1.96% | ― | ― | |
70 Neutral | C$276.49M | 12.88 | 50.74% | 6.44% | -2.76% | -12.20% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | C$648.34M | 3.81 | 36.24% | 2.20% | -1.35% | 496.34% | |
51 Neutral | C$256.87M | -143.14 | 0.84% | ― | 8.11% | 97.99% |
Queen’s Road Capital Investment Ltd. has agreed to invest US$20 million in ATHA Energy Corp. through a five-year convertible debenture carrying a 12% coupon and convertible into ATHA shares at C$0.85, pending regulatory approval expected by the end of the month. The deal deepens Queen’s Road Capital’s exposure to the uranium sector by backing ATHA Energy’s extensive portfolio of uranium exploration assets in Canada, including the Angilak Uranium Project in Nunavut and interests in Athabasca Basin projects, and complements the financier’s existing positions in NexGen Energy and IsoEnergy, reinforcing its strategy of targeting high-quality resource projects in secure jurisdictions.
The most recent analyst rating on (TSE:QRC) stock is a Buy with a C$13.50 price target. To see the full list of analyst forecasts on Queen’s Road Capital Investment stock, see the TSE:QRC Stock Forecast page.
Queen’s Road Capital Investment Ltd. has announced the continuation of its normal course issuer bid (NCIB) for another 12 months, allowing the company to repurchase up to 1,760,000 common shares, approximately 3.45% of its outstanding shares. This move is intended to address potential undervaluation in the market price of its shares, with purchases depending on favorable market conditions. The continuation of the NCIB reflects the company’s ongoing strategy to manage its share capital effectively, potentially benefiting shareholders by enhancing the value of remaining shares.
The most recent analyst rating on (TSE:QRC) stock is a Hold with a C$7.50 price target. To see the full list of analyst forecasts on Queen’s Road Capital Investment stock, see the TSE:QRC Stock Forecast page.
Queen’s Road Capital Investment Ltd. announced after-tax earnings of US$115 million for the fiscal year 2025, with a significant portfolio of convertible debentures and liquid equity investments. The company reported a strong start to 2026, driven by high demand for uranium, copper, and gold equities, which constitute a major part of its portfolio. Shareholder support remains robust, with a high participation rate in the dividend reinvestment plan, and the company plans to move to a semi-annual dividend schedule in 2026.
The most recent analyst rating on (TSE:QRC) stock is a Hold with a C$7.50 price target. To see the full list of analyst forecasts on Queen’s Road Capital Investment stock, see the TSE:QRC Stock Forecast page.